These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 24040854)

  • 1. The bone evaluation study (BEST): patient care and persistence to treatment of osteoporosis in Germany.
    Hadji P; Klein S; Häussler B; Kless T; Linder R; Rowinski-Jablokow M; Verheyen F; Gothe H
    Int J Clin Pharmacol Ther; 2013 Nov; 51(11):868-72. PubMed ID: 24040854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoporosis prevalence and characteristics of treated and untreated nursing home residents with osteoporosis.
    Zarowitz BJ; Cheng LI; Allen C; O'Shea T; Stolshek B
    J Am Med Dir Assoc; 2015 Apr; 16(4):341-8. PubMed ID: 25726417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoporosis and vertebral compression fractures-continued missed opportunities.
    Freedman BA; Potter BK; Nesti LJ; Giuliani JR; Hampton C; Kuklo TR
    Spine J; 2008; 8(5):756-62. PubMed ID: 18343730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term persistence with anti-osteoporosis drugs after fracture.
    Klop C; Welsing PM; Elders PJ; Overbeek JA; Souverein PC; Burden AM; van Onzenoort HA; Leufkens HG; Bijlsma JW; de Vries F
    Osteoporos Int; 2015 Jun; 26(6):1831-40. PubMed ID: 25822104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-osteoporotic treatments in France: initiation, persistence and switches over 6 years of follow-up.
    Belhassen M; Confavreux CB; Cortet B; Lamezec L; Ginoux M; Van Ganse E
    Osteoporos Int; 2017 Mar; 28(3):853-862. PubMed ID: 27766368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.
    Perreault S; Dragomir A; Desgagné A; Blais L; Rossignol M; Blouin J; Moride Y; Ste-Marie LG; Fernandès JC
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):685-95. PubMed ID: 15645517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How the knowledge of fracture risk might influence adherence to oral therapy of osteoporosis in Italy: the ADEOST study.
    Gonnelli S; Caffarelli C; Rossi S; Di Munno O; Malavolta N; Isaia G; Muratore M; D'Avola G; Gatto S; Minisola G; Nuti R
    Aging Clin Exp Res; 2016 Jun; 28(3):459-68. PubMed ID: 26873817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence and persistence in patients with severe osteoporosis treated with teriparatide.
    Ziller V; Zimmermann SP; Kalder M; Ziller M; Seker-Pektas B; Hellmeyer L; Hadji P
    Curr Med Res Opin; 2010 Mar; 26(3):675-81. PubMed ID: 20078188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased treatment persistence and its determinants in women with osteoporosis with prior fracture compared to those without fracture.
    Jacob L; Dreher M; Kostev K; Hadji P
    Osteoporos Int; 2016 Mar; 27(3):963-969. PubMed ID: 26519418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A claims database analysis of persistence with alendronate therapy and fracture risk in post-menopausal women with osteoporosis.
    Gold DT; Martin BC; Frytak JR; Amonkar MM; Cosman F
    Curr Med Res Opin; 2007 Mar; 23(3):585-94. PubMed ID: 17355739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teriparatide treatment patterns in osteoporosis and subsequent fracture events: a US claims analysis.
    Bonafede MM; Shi N; Bower AG; Barron RL; Grauer A; Chandler DB
    Osteoporos Int; 2015 Mar; 26(3):1203-12. PubMed ID: 25567774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of medication adherence on health care utilization and productivity: self-reported data from a cohort of postmenopausal women on osteoporosis therapy.
    Wade SW; Satram-Hoang S; Nadkar A; Macarios D; Tosteson AN
    Clin Ther; 2011 Dec; 33(12):2006-15. PubMed ID: 22099387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
    Adachi JD; Hanley DA; Lorraine JK; Yu M
    Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a program of integrated care to reduce recurrent osteoporotic fractures.
    Goltz L; Degenhardt G; Maywald U; Kirch W; Schindler C
    Pharmacoepidemiol Drug Saf; 2013 Mar; 22(3):263-70. PubMed ID: 23296590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who is at risk of receiving inadequate care for osteoporosis following fragility fractures? A retrospective study.
    Blecher R; Wasrbrout Z; Arama Y; Kardosh R; Agar G; Mirovsky Y
    Isr Med Assoc J; 2013 Oct; 15(10):634-8. PubMed ID: 24266091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic adherence to osteoporosis treatment.
    Tomková S; Telepková D; Vanuga P; Killinger Z; Sulková I; Celec P; Payer J
    Int J Clin Pharmacol Ther; 2014 Aug; 52(8):663-8. PubMed ID: 24887334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physician perception of patient adherence compared to patient adherence of osteoporosis medications from pharmacy claims.
    Copher R; Buzinec P; Zarotsky V; Kazis L; Iqbal SU; Macarios D
    Curr Med Res Opin; 2010 Apr; 26(4):777-85. PubMed ID: 20095797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term impact of adherence to oral bisphosphonates on osteoporotic fracture incidence.
    Sampalis JS; Adachi JD; Rampakakis E; Vaillancourt J; Karellis A; Kindundu C
    J Bone Miner Res; 2012 Jan; 27(1):202-10. PubMed ID: 21976304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence to medical treatment of osteoporosis in women at three different clinical settings--a historical cohort study.
    Nielsen DS; Langdahl BL; Sørensen OH; Sørensen HA; Brixen KT
    Scand J Public Health; 2010 Jul; 38(5):502-7. PubMed ID: 20484306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.